ANDA 062745

LILLY

FDA Drug Application

Application #062745

Application Sponsors

ANDA 062745

LILLY

Marketing Status

• Discontinued: 001
• Discontinued: 002

Application Products

001	TABLET;ORAL	EQ 250MG BASE	0	KEFLET	CEPHALEXIN
002	TABLET;ORAL	EQ 500MG BASE	0	KEFLET	CEPHALEXIN

FDA Submissions

	ORIG	1	AP	1986-12-01
LABELING; Labeling	SUPPL	2	AP	1992-02-05
LABELING; Labeling	SUPPL	3	AP	1992-02-05

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62745
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)